Genetic study of von Willebrand factor antigen levels ≤ 50 IU/dL identifies variants associated with increased risk of von Willebrand disease and bleeding
Rachel K. Friedman , Adam S. Heath , Jennifer E. Huffman , James T. Baker , Natalie R. Hasbani , Sarah A. Gagliano Taliun , Ming–Huei Chen , Tom E. Howard , Joshua P. Lewis , Nathan Pankratz , Snehal Patil , Alex P. Reiner , Florian Thibord , Lisa R. Yanek , Jie Yao , Hung–Hsin Chen , Joanne E. Curran , Nauder Faraday , Xiuqing Guo , Marsha M. Wheeler , Paul S. de Vries
{"title":"Genetic study of von Willebrand factor antigen levels ≤ 50 IU/dL identifies variants associated with increased risk of von Willebrand disease and bleeding","authors":"Rachel K. Friedman , Adam S. Heath , Jennifer E. Huffman , James T. Baker , Natalie R. Hasbani , Sarah A. Gagliano Taliun , Ming–Huei Chen , Tom E. Howard , Joshua P. Lewis , Nathan Pankratz , Snehal Patil , Alex P. Reiner , Florian Thibord , Lisa R. Yanek , Jie Yao , Hung–Hsin Chen , Joanne E. Curran , Nauder Faraday , Xiuqing Guo , Marsha M. Wheeler , Paul S. de Vries","doi":"10.1016/j.jtha.2025.04.029","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>von Willebrand disease (VWD) is a common inherited bleeding disorder caused by low levels or activity of circulating von Willebrand factor (VWF). Genetic susceptibility to VWF antigen (VWF:Ag) below normal (<span><math><mrow><mo>≤</mo></mrow></math></span> 50 IU/dL) in the general population is underexplored.</div></div><div><h3>Objectives</h3><div>To identify genetic variants influencing VWF:Ag levels <span><math><mrow><mo>≤</mo></mrow></math></span> 50 IU/dL.</div></div><div><h3>Methods</h3><div>We performed a genome-wide association study in 926 cases with VWF:Ag levels <span><math><mrow><mo>≤</mo></mrow></math></span> 50 IU/dL and 12 846 controls from 7 studies from the Trans-Omics for Precision Medicine program. We then examined whether significant genome-wide findings were also associated with clinical diagnosis of VWD in 5 biobanks with 708 VWD cases and 1 286 069 controls, and with 6 bleeding and thrombotic disorders in FinnGen.</div></div><div><h3>Results</h3><div>Variants at 2 loci were associated (<em>P</em> < 5 × 10<sup>−9</sup>) with VWF:Ag levels <span><math><mrow><mo>≤</mo></mrow></math></span> 50 IU/dL: <em>ABO</em> and <em>VWF</em>. The <em>VWF</em> index variant, p.Tyr1584Cys, is a rare (0.22%) missense variant with odds ratio (OR) of 78.58, while the <em>ABO</em> index variant is a common intronic variant with a smaller effect (OR = 2.52). Notably, both <em>VWF</em> (OR = 7.16) and <em>ABO</em> (OR = 1.57) variants were also associated (<em>P</em> < .025) with diagnosed VWD. Among p.Tyr1584Cys heterozygotes, the penetrance of VWF:Ag levels <span><math><mrow><mo>≤</mo></mrow></math></span> 50 IU/dL was 24.2% and the penetrance of diagnosed VWD was 0.3%. p.Tyr1584Cys was associated (<em>P</em> < .0042) with increased odds of heavy menstrual bleeding (OR = 1.27), iron deficiency anemia (OR = 1.55), and intrapartum hemorrhage (OR = 2.20), but decreased odds of deep vein thrombosis (OR = 0.54).</div></div><div><h3>Conclusions</h3><div>Although there are currently conflicting interpretations of pathogenicity p.Tyr1584Cys, our results suggest that it is a low penetrance pathogenic variant that contributes to VWF:Ag levels <span><math><mrow><mo>≤</mo></mrow></math></span> 50 IU/dL, bleeding, and VWD.</div></div>","PeriodicalId":17326,"journal":{"name":"Journal of Thrombosis and Haemostasis","volume":"23 8","pages":"Pages 2410-2421"},"PeriodicalIF":5.0000,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Thrombosis and Haemostasis","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1538783625003113","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
von Willebrand disease (VWD) is a common inherited bleeding disorder caused by low levels or activity of circulating von Willebrand factor (VWF). Genetic susceptibility to VWF antigen (VWF:Ag) below normal ( 50 IU/dL) in the general population is underexplored.
Objectives
To identify genetic variants influencing VWF:Ag levels 50 IU/dL.
Methods
We performed a genome-wide association study in 926 cases with VWF:Ag levels 50 IU/dL and 12 846 controls from 7 studies from the Trans-Omics for Precision Medicine program. We then examined whether significant genome-wide findings were also associated with clinical diagnosis of VWD in 5 biobanks with 708 VWD cases and 1 286 069 controls, and with 6 bleeding and thrombotic disorders in FinnGen.
Results
Variants at 2 loci were associated (P < 5 × 10−9) with VWF:Ag levels 50 IU/dL: ABO and VWF. The VWF index variant, p.Tyr1584Cys, is a rare (0.22%) missense variant with odds ratio (OR) of 78.58, while the ABO index variant is a common intronic variant with a smaller effect (OR = 2.52). Notably, both VWF (OR = 7.16) and ABO (OR = 1.57) variants were also associated (P < .025) with diagnosed VWD. Among p.Tyr1584Cys heterozygotes, the penetrance of VWF:Ag levels 50 IU/dL was 24.2% and the penetrance of diagnosed VWD was 0.3%. p.Tyr1584Cys was associated (P < .0042) with increased odds of heavy menstrual bleeding (OR = 1.27), iron deficiency anemia (OR = 1.55), and intrapartum hemorrhage (OR = 2.20), but decreased odds of deep vein thrombosis (OR = 0.54).
Conclusions
Although there are currently conflicting interpretations of pathogenicity p.Tyr1584Cys, our results suggest that it is a low penetrance pathogenic variant that contributes to VWF:Ag levels 50 IU/dL, bleeding, and VWD.
期刊介绍:
The Journal of Thrombosis and Haemostasis (JTH) serves as the official journal of the International Society on Thrombosis and Haemostasis. It is dedicated to advancing science related to thrombosis, bleeding disorders, and vascular biology through the dissemination and exchange of information and ideas within the global research community.
Types of Publications:
The journal publishes a variety of content, including:
Original research reports
State-of-the-art reviews
Brief reports
Case reports
Invited commentaries on publications in the Journal
Forum articles
Correspondence
Announcements
Scope of Contributions:
Editors invite contributions from both fundamental and clinical domains. These include:
Basic manuscripts on blood coagulation and fibrinolysis
Studies on proteins and reactions related to thrombosis and haemostasis
Research on blood platelets and their interactions with other biological systems, such as the vessel wall, blood cells, and invading organisms
Clinical manuscripts covering various topics including venous thrombosis, arterial disease, hemophilia, bleeding disorders, and platelet diseases
Clinical manuscripts may encompass etiology, diagnostics, prognosis, prevention, and treatment strategies.